Natriumklorid-Glucos, Viaflo Baxter (Sodium Chloride, Glucose)

Sodium chloride raises plasma sodium and chloride levels, expanding extracellular fluid volume and restoring osmotic balance. Glucose is rapidly metabolized, supplying immediate energy and stimulating insulin release, which helps shift potassium into cells and supports overall metabolic function during IV therapy.

The appropriate dose is determined by the prescribing clinician based on the patient’s fluid status, electrolyte measurements, blood glucose level, and the specific clinical situation. Dosage is individualized and should follow the prescriber’s orders.

Safety data in pregnancy and lactation are limited. The product should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and it should be prescribed by a qualified healthcare professional.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain where required), and import documentation.

Unlike normal saline, Natriumklorid-Glucos also contains glucose, providing both electrolyte balance and an energy source. Compared with plain dextrose solutions, it adds sodium and chloride, making it suitable for patients who need simultaneous fluid, electrolyte, and carbohydrate replacement.

The injection solution should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Use aseptic technique when preparing the infusion and discard any solution that appears cloudy or discolored.

It is administered intravenously, typically as an infusion diluted in compatible IV fluids. The rate and volume are set by the prescriber according to the patient’s clinical condition, and infusion should be monitored for signs of fluid overload or electrolyte imbalance.

Serious risks include severe hypernatremia, severe hyperglycemia, fluid overload leading to pulmonary edema, and allergic reactions such as anaphylaxis. Prompt recognition and management of these events are essential, and patients should be closely monitored during infusion.

Patients with known hypersensitivity to sodium chloride or glucose solutions, those with uncontrolled hypernatremia, severe uncontrolled diabetes, or conditions predisposing to fluid overload should avoid this product unless a clinician determines that benefits outweigh the risks.